Form D · Other
Lucid Scientific, Inc.
Atlanta, GA · CIK 0001825385
Offering snapshot reported Sep 6, 2023 · SEC filing
- Reported sold
- $8.88M Offering amount: $9.16M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 25, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 6, 2023 | Initial | $8,884,494 | No comparison | 13 | SEC filing |
| Sep 22, 2020 | Initial | $3,569,128 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-491442
Source: Form D, filed Sep 6, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ian W. Hunter | Director |
| Samuel Walker Inman | Director, Executive |
| Ehsan Jabbarzadeh | Director |
| Dr. Gustavo Mahler | Director |
| Reinhard Vogt | Director |
Issuer details
Industry: Other (See others in industry)
Address:
311 Ferst Drive Nw
Atlanta, GA, 30332
Atlanta, GA, 30332